Arcus Biosciences, Inc. employees and revenue per employee

RCUS · Biotechnology · $2.25B market cap

Arcus Biosciences, Inc. had 601 employees at the end of fiscal Dec 2025, down 4.1% from a year earlier. Revenue for the year was $247M, down 4.3% from a year earlier, or $411K per employee. Revenue fell, and headcount fell or held flat with it.

Employees

601

-4.1% YoY

Revenue

$247M

-4.3% YoY

Revenue / employee

$411K

Peer median $457K

Rank in industry

61 of 110

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018
024724944'18'19'20'21'22'23'24'25Revenue 2957Staff 556

Hover a year for the numbers.

RCUS employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025601$247M$411K-4.1%-4.3%
Dec 2024627$258M$411K+8.7%+120.5%
Dec 2023577$117M$203K+15.4%+4.5%
Dec 2022500$112M$224K+36.6%-70.8%
Dec 2021366$383M$1.05M+55.1%+391.0%
Dec 2020236$78.0M$331K+69.8%+420.0%
Dec 2019139$15.0M$108K+28.7%+79.6%
Dec 2018108$8.4M$77K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
236'20366'21500'22577'23627'24601'25
Revenue per employee, last six fiscal years
$331K'20$1.05M'21$224K'22$203K'23$411K'24$411K'25

Arcus Biosciences, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
LGND
Ligand Pharmaceuticals Incorporated
47$268M$5.70MLeaner
ANAB
AnaptysBio, Inc.
104$235M$2.26MLeaner
IDYA
IDEAYA Biosciences, Inc.
145$219M$1.51MEfficient growth
PBYI
Puma Biotechnology, Inc.
179$228M$1.28MHiring into decline
ARVN
Arvinas, Inc.
246$263M$1.07MContracting
VCEL
Vericel Corporation
398$276M$694KEfficient growth
ADPT
Adaptive Biotechnologies Corporation
624$277M$444KEfficient growth
RCUS
Arcus Biosciences, Inc.
601$247M$411KContracting
IOVA
Iovance Biotherapeutics, Inc.
975$264M$270KEfficient growth
Every Healthcare company

Questions about Arcus Biosciences, Inc.

How many employees does Arcus Biosciences, Inc. have?
Arcus Biosciences, Inc. reported 601 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is down 4.1% from a year earlier.
What is Arcus Biosciences, Inc.'s revenue per employee?
Arcus Biosciences, Inc. brought in $247M of revenue in fiscal Dec 2025, which is $411K per employee. That ranks 61 of 110 companies we track in Biotechnology, where the median is $457K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare RCUS with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Arcus Biosciences, Inc.'s annual reports (Form 10-K), latest filed February 25, 2026. This is data, not a recommendation to buy or sell RCUS.